)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Arcadia Biosciences
Arcadia Biosciences (RKDA) investor relations material
Arcadia Biosciences Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2026 earnings summary12 Nov, 2026
Executive summary
Zola Q3 revenue rose 24% YoY to $1.619M, a record quarterly level driven by strong summer-program volumes; nine-month revenue increased 5%.
Q3 net income was $1.755M, including a $2.574M warrant and option liability fair-value gain; nine-month net loss widened to $8.896M, and cash is insufficient for anticipated needs over the next 12 months.
Financial highlights
Q3 revenue increased $317K, or 24%, to $1.619M; nine-month revenue rose $205K, or 5%, to $4.162M.
Q3 cost of revenue fell 14% to $760K, down $124K, partly due to a $175K tariff refund; nine-month cost fell 5% to $2.272M, down $117K.
Q3 operating loss narrowed to $839K from $1.152M; nine-month operating loss widened to $2.114M from $1.125M. Nine-month operating expenses rose 23% to $6.276M.
Q3 net income was $1.755M versus $856K; nine-month net loss was $8.896M versus $1.003M, including investment and financing-related losses.
Outlook and guidance
A newly formulated Zola Espresso in a 1-liter resealable carton, with just over 100 mg of caffeine, begins shipping in November 2026; leading customers made pre-launch commitments.
Zola Original, Original with Pulp and Espresso slim cans are planned for H1 2027.
Summer-program growth has created new distribution opportunities for 2027, including Texas and other regions.
Merger, acquisition and other strategic alternatives are under evaluation; no assurance was given that funding or a transaction will be secured.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Arcadia Biosciences
- All AGM proposals passed, including director election, stock issuance, and reverse split.RKDA
AGM 2026 - Q2 2026 net loss widened to $6.3M on flat sales, but Zola sales rebounded post-quarter.RKDAQ2 2026
- Board seeks approval for director election, equity issuance, new plan, reverse split, and auditor change.RKDAProxy filing
- Shareholders will vote on director election, equity issuance, reverse split, and governance proposals.RKDAProxy filing
- Resale registration covers 11.9M shares from options; proceeds fund operations if exercised.RKDARegistration filing
- Net loss of $4.4M and low cash raise substantial doubt about ongoing operations.RKDAQ1 2026
- Zola revenues grew 17% year-over-year, but total revenues fell and further funding is needed.RKDAQ4 2025
- Registering 1.67M shares for resale, with proceeds for working capital amid going concern risk.RKDARegistration Filing
- Q2 net income up 30% on asset sales and 42% Zola growth, but liquidity remains a concern.RKDAQ2 2024
Next Arcadia Biosciences earnings date
Q4 202625 Mar, 2027
Arcadia Biosciences
Next Arcadia Biosciences earnings date
Q4 202625 Mar, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Arcadia Biosciences, Inc., a food ingredient company, engages in the development of a portfolio of plant-based agronomic products worldwide. Its products focus on enhancing agricultural traits and crop productivity to improve human health and nutrition, reduce the environmental impact of agriculture, and create valuable solutions for crops. The company develops its product pipeline under GoodWheat brand products in six areas, such as enhanced baking quality wheat with reduced gluten; enhanced nutritional wheat with more fiber; enhanced flour from select wheat varieties without gluten; antioxidant wheat with increased antioxidant activity; and white winter wheat for premium pasta production. It provides its health ingredients for use in food products under the GoodWheat brand name directly to consumer packaged goods companies and their ingredient suppliers.